New marburg vaccine trial aims to protect against deadly virus

NCT ID NCT06620003

First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 30 times

Summary

This study tests an experimental vaccine against Marburg virus, a rare but severe disease. About 200 healthy adults will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal is to see if the vaccine is safe and prompts the body to fight the virus.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MARBURG VIRUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Optimal Research; LLC

    Huntsville, Alabama, 35802, United States

  • Optimal Research; LLC

    Melbourne, Florida, 32934, United States

  • Optimal Research; LLC

    Peoria, Illinois, 61614, United States

  • Synexus Clinical Research US, Inc.

    Phoenix, Arizona, 85020, United States

  • Synexus Clinical Research US, Inc.

    Chicago, Illinois, 60602, United States

  • Synexus Clinical Research US, Inc.

    San Antonio, Texas, 78229, United States

  • Synexus Clinical Research US; Inc.

    Dallas, Texas, 75234, United States

Conditions

Explore the condition pages connected to this study.